Scientists have got success with a new injection of HIV. Taking this injection once a year can reduce the risk of HIV ...

Offering mailed self-testing for HIV encouraged patients to test themselves for HIV but require methods of improving ...

Older adults with HIV are at significantly higher risk for cutaneous malignancies when compared with younger patients with HIV.

HIV self-testing remains underutilized among not only the general public, but especially people who use drugs.

Data from a very early-phase trial shows that the drug is safe and remains in the body for up to 56 weeks. From two ...

Incident HCV infection more than doubled among HIV-positive MSM with no history of injection drug use between 1995 and 2023.

Research on the presence of thyroid abnormalities in HIV showed that patients with HIV are at risk for developing a variety of thyroid disorders.

In the general population, frailty is an aging-related risk factor for poor outcomes; individuals experiencing frailty face ...

The advent of effective antiretroviral therapy (ART) has increased the lifespan of many people living with HIV. As a result, ...